SlideShare a Scribd company logo

Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017

•
•
Attività scientifica
Attività scientifica

CLMMC ADE Gastroenterologia

Health & Medicine
1 of 1
Download to read offline
Emorragie gastrointestinali ADE studenti V e VI anno CLMMC 28 NOVEMBRE 2017 Aula 7 - Ore 14.30-16.30 Emorragie acute superiori ed inferiori ed emorragie occulte: approccio clinico Dr. ssa Patrizia Ricci Emorragie da rottura di varici esofagee Prof. Stefano Fiorucci Emorragie GI approccio radiologico e casi clinici Dr. Alberto Rebonato Prof. Stefano Fiorucci Sezione di Gastroenterologia (coordinatore) Piazza L. Severi, 1- 06132 Perugia - www.gastroenterologia.unipg.it Universita’ degli Studi di Perugia CLMM C

Recommended

Mutignani update nel trattamento endoscopico della litiasi biliare
Mutignani update nel trattamento endoscopico della litiasi biliareMutignani update nel trattamento endoscopico della litiasi biliare
Mutignani update nel trattamento endoscopico della litiasi biliare
Attività scientifica
 
Nanotechnology update A seminar by Prof. Tatiana Tennikova
Nanotechnology update A seminar by Prof. Tatiana TennikovaNanotechnology update A seminar by Prof. Tatiana Tennikova
Nanotechnology update A seminar by Prof. Tatiana Tennikova
Attività scientifica
 
Microbiota 2019
Microbiota 2019 Microbiota 2019
Microbiota 2019
Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
Attività scientifica
 
Microbiota update perugia-
Microbiota update perugia- Microbiota update perugia-
Microbiota update perugia-
Attività scientifica
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
Attività scientifica
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingPortal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
Attività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAOcaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Attività scientifica
 

Recommended

Mutignani update nel trattamento endoscopico della litiasi biliare
Mutignani update nel trattamento endoscopico della litiasi biliareMutignani update nel trattamento endoscopico della litiasi biliare
Mutignani update nel trattamento endoscopico della litiasi biliare
Attività scientifica
 
Nanotechnology update A seminar by Prof. Tatiana Tennikova
Nanotechnology update A seminar by Prof. Tatiana TennikovaNanotechnology update A seminar by Prof. Tatiana Tennikova
Nanotechnology update A seminar by Prof. Tatiana Tennikova
Attività scientifica
 
Microbiota 2019
Microbiota 2019 Microbiota 2019
Microbiota 2019
Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
Attività scientifica
 
Microbiota update perugia-
Microbiota update perugia- Microbiota update perugia-
Microbiota update perugia-
Attività scientifica
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
Attività scientifica
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingPortal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
Attività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAOcaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Attività scientifica
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
Attività scientifica
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Attività scientifica
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
Attività scientifica
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Attività scientifica
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Attività scientifica
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisDigestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Attività scientifica
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
Attività scientifica
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
Attività scientifica
 
New official web site
New official web siteNew official web site
New official web site
Attività scientifica
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
Attività scientifica
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
Attività scientifica
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016
Attività scientifica
 
Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016
Attività scientifica
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
Attività scientifica
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citations
Attività scientifica
 
Update emorragie digestive 2015
Update emorragie digestive 2015Update emorragie digestive 2015
Update emorragie digestive 2015
Attività scientifica
 
Trends in Molecular Medicine
Trends in Molecular Medicine Trends in Molecular Medicine
Trends in Molecular Medicine
Attività scientifica
 
Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015
Attività scientifica
 
Expert opinion on therapeutic patent
Expert opinion on therapeutic patentExpert opinion on therapeutic patent
Expert opinion on therapeutic patent
Attività scientifica
 
Bar502 and cholestasis
Bar502 and cholestasisBar502 and cholestasis
Bar502 and cholestasis
Attività scientifica
 

More Related Content

More from Attività scientifica

More from Attività scientifica (20)

Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisDigestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
 
New official web site
New official web siteNew official web site
New official web site
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016
 
Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citations
 
Update emorragie digestive 2015
Update emorragie digestive 2015Update emorragie digestive 2015
Update emorragie digestive 2015
 
Trends in Molecular Medicine
Trends in Molecular Medicine Trends in Molecular Medicine
Trends in Molecular Medicine
 
Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015
 
Expert opinion on therapeutic patent
Expert opinion on therapeutic patentExpert opinion on therapeutic patent
Expert opinion on therapeutic patent
 
Bar502 and cholestasis
Bar502 and cholestasisBar502 and cholestasis
Bar502 and cholestasis
 

Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017

  • 1. Emorragie gastrointestinali ADE studenti V e VI anno CLMMC 28 NOVEMBRE 2017 Aula 7 - Ore 14.30-16.30 Emorragie acute superiori ed inferiori ed emorragie occulte: approccio clinico Dr. ssa Patrizia Ricci Emorragie da rottura di varici esofagee Prof. Stefano Fiorucci Emorragie GI approccio radiologico e casi clinici Dr. Alberto Rebonato Prof. Stefano Fiorucci Sezione di Gastroenterologia (coordinatore) Piazza L. Severi, 1- 06132 Perugia - www.gastroenterologia.unipg.it Universita’ degli Studi di Perugia CLMM C